Tuberculosis (TB) is one of the world's most common infectious diseases. Although infection with the Mycobacterium ...

Tuberculosis is one of the world's leading infectious diseases. Infection with the bacterium Mycobacterium tuberculosis primarily affects the lungs, but in up to 25 percent of all infected individuals ...

In the study, published in Science Translational Medicine on Nov. 5, researchers identified proteins expressed on the surface ...

Single-cell RNA sequencing identified distinct immune profiles in extrapulmonary TB, linking interferon–IL-1 signaling to disease progression and paving the way for blood-based diagnostics.

Using precise molecular techniques, including single-cell RNA sequencing, the team showed that this process is mediated in part by the effects of CD4 T cells on CD8 T cells – another subset of white ...

A large-scale screen of tuberculosis proteins has revealed several possible antigens that could be developed as a new vaccine ...

LITTLE ROCK, Ark. — The National Institutes of Health (NIH) has awarded UAMS researchers $3.7 million to pursue a possible breakthrough in tuberculosis (TB) research. While we may not see much TB in ...

Scientists might be on the verge of developing a new vaccine to combat tuberculosis, one of the deadliest diseases in the ...

Scientists may be on the verge of developing a new vaccine to combat tuberculosis, one of the deadliest diseases in the world. In 2023, nearly 10.8 million people were infected with tuberculosis and m ...

Researchers in Boston are working to determine if an old tuberculosis vaccine could be the key to treating type 1 diabetes.